Rare diseases
Investigational molecules
Locations
Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous Ocrelizumab in Children and Adolescents with Relapsing‑Remitting Multiple Sclerosis
PolandSafety and efficacy of venetoclax, obinutuzumab and daratumumab in adult patients with relapsed chronic lymphocytic leukemia
PolandELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
PolandStudy of human normal immunoglobulin to prevent major infections in patients with hypogammaglobulinemia and autoimmune/rheumatic disease on B‑cell depletion therapy
PolandA study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
PolandA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
PolandA study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma
PolandA study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes
PolandA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
PolandA study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.
PolandA study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer
PolandA study to optimize the delivery of AAV2-GDNF and gadoteridol into the brain for patients with Parkinson's disease
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
